The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

BACKGROUND: There have been few treatment advances for patients with glioblastoma (GBM) despite increasing scientific understanding of the disease. While factors such as intrinsic tumor biology and drug delivery are challenges to developing efficacious therapies, it is unclear whether the current cl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Vanderbeek, Alyssa M, Rahman, Rifaquat, Fell, Geoffrey, Ventz, Steffen, Chen, Tianqi, Redd, Robert, Parmigiani, Giovanni, Cloughesy, Timothy F, Wen, Patrick Y, Trippa, Lorenzo, Alexander, Brian M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Meta-Analyses
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280141/
https://ncbi.nlm.nih.gov/pubmed/29518210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados